Objective: Antipsychotic medications may cause tardive dyskinesia (TD), an often-irreversible movement disorder characterized by involuntary movements that are typically stereotypic, choreiform, or dystonic and may impair quality of life. This study evaluated others' perceptions of abnormal TD movements in professional and social situations.
Methods: This was an experimental, randomized, blinded, digital survey in a general population sample. Participants were randomized 1:1 into a test or control group to view a video of a professional actor simulating TD movements or no TD movements prior to completing surveys on employment, dating, and friendship domains. Assessments for mild-to-moderate and moderate-to-severe TD movements were conducted separately. Authenticity of abnormal movements and Abnormal Involuntary Movement Scale (AIMS) scores were evaluated by physician experts.
Results: Surveys were completed by 2,400 participants each for mild-to-moderate and moderate-to-severe TD. In all domains, participants responded significantly less favorably to persons with TD movements (both mild-to-moderate and moderate-to-severe) than those without TD movements. Fewer participants in the test versus control group for mild-to-moderate and moderate-to-severe TD, respectively, considered the candidate as a potential employee (29.2% and 22.7% fewer), found him/her attractive (20.5% and 18.7% fewer), and were interested in becoming friends with him/her (12.3% and 16.5% fewer).
Conclusion: Professional actors simulating TD movements were perceived more negatively than those without TD movements in employment, dating, and friendship domains. To our knowledge, this is the first randomized study to quantify professional and social stigma associated with TD movements that may reduce opportunities for gainful employment, marital status, and an effective support system.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813323 | PMC |
http://dx.doi.org/10.9758/cpn.2022.20.1.154 | DOI Listing |
J Clin Med
January 2025
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo 173-8610, Japan.
This study aimed to examine the natural progression of the cranial shape from the end of helmet therapy for deformational plagiocephaly to 1 year of age. This study included infants with moderate to severe deformational plagiocephaly who began treatment at our department between December 2022 and July 2023. The cranial shape was assessed using a 3D scanner (VECTRAH2) at the start of treatment, end of treatment, and 12 months of age.
View Article and Find Full Text PDFPsychogeriatrics
January 2025
National Institute of Nursing Education, Chandigarh, India.
Background: Older people often require support due to age-related health issues, thereby increasing their dependency on caregivers. The caregivers often experience burdens of varying nature.
Objective: To assess the dependency level of the elderly and the challenges faced by their caregivers.
AIMS Neurosci
November 2024
Research Unit (UR17JS01) Sports Performance, Health & Society, Higher Institute of Sport and Physical Education of Ksar-Said, Universite de La Manouba, Tunis 2010, Tunisia.
Background: Parkinson's disease (PD) remains incurable and its prevalence is increasing as the population ages. Although physical activity is considered a therapeutic treatment to slow the progression of the disease, it is considered to be an effective non-pharmacological adjuvant to medication to improve the symptom management.
Methods: The training program was offered for all the participants (N = 50) in three non-consecutive sessions per week for 60 minutes and a total duration of 12 to 16 months.
Clin Pharmacokinet
January 2025
Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1205, Geneva, Switzerland.
Background And Objective: Fexofenadine is commonly used as a probe substrate to assess P-glycoprotein (Pgp) activity. While its use in healthy volunteers is well documented, data in older adult and polymorbid patients are lacking. Age- and disease-related physiological changes are expected to affect the pharmacokinetics of fexofenadine.
View Article and Find Full Text PDFInt J Rheum Dis
January 2025
Department of Rheumatism, The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, China.
Objective: To analyze the diagnostic value of a combined test of anti-cyclic citrullinated peptide antibody (CCP), anti-keratin antibody (AKA), anti-carbamylated protein antibody (Carp antibody), and rheumatoid factor (RF) in the early diagnosis of rheumatoid arthritis (RA).
Methods: Sixty cases of RA admitted to our hospital from 2021 to 2022 (observation group) were selected, along with 50 cases of healthy physical examiners (control group). The results of CCP antibody, AKA antibody, Carp antibody, and rheumatoid factor in both groups were analyzed: the concentration of CCP antibody, AKA antibody, Carp antibody, and rheumatoid factor in each group at different levels; the comparison of various testing methods with the "gold standard" test; and the ROC curve analysis of CCP antibody, AKA antibody, Carp antibody, and rheumatoid factor in each group.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!